Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival.

Tonnessen-Murray CA, Frey WD, Rao SG, Shahbandi A, Ungerleider NA, Olayiwola JO, Murray LB, Vinson BT, Chrisey DB, Lord CJ, Jackson JG.

J Cell Biol. 2019 Sep 17. pii: jcb.201904051. doi: 10.1083/jcb.201904051. [Epub ahead of print]

PMID:
31530580
2.

Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity.

Shahbandi A, Jackson JG.

NPJ Precis Oncol. 2019 Jan 7;3:1. doi: 10.1038/s41698-018-0074-x. eCollection 2019.

3.

Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment.

Ungerleider NA, Rao SG, Shahbandi A, Yee D, Niu T, Frey WD, Jackson JG.

Breast Cancer Res. 2018 Oct 1;20(1):115. doi: 10.1186/s13058-018-1044-5.

Supplemental Content

Loading ...
Support Center